United Theranostics Overview
Precision Cancer Care, Closer To Home
United Theranostics expands meaningful access to advanced molecular imaging, radiopharmaceutical therapy, clinical research, and coordinated support in community practice.
Our Practice
A National Practice Built For Meaningful Access
United Theranostics was founded by experts in oncology, nuclear medicine, radiology, informatics, and clinical operations to bring the promise of theranostics directly to patients and referring providers.
Our centers support individualized treatment planning by combining state-of-the-art molecular imaging, targeted radiopharmaceutical therapies, insurance coordination, and ongoing clinical follow-up.
Care Designed Around The Patient
At United Theranostics, there is no waiting time to begin care after the initial consultation. Our team helps patients and referring offices move through scheduling, insurance assistance, treatment planning, and follow-up with clarity and support.
Our Vision
Making Molecular-Level Care The Standard
Our vision is to transform cancer treatment by making precision, molecular-level care the standard for patients, regardless of location.
Patient-Centered Care
Every decision and treatment plan is guided by what is best for the individual patient.
Innovation
We embrace advances in molecular imaging and targeted therapies to improve outcomes.
Collaboration
Our multidisciplinary team works closely with referring physicians to support coordinated care.
Compassion
We support patients and families at every step, from diagnosis through follow-up.
Leadership
Executive Team
United Theranostics is led by clinical, operational, financial, and technology leaders focused on expanding access to advanced care.
Robert Cherney
Seth Van Voorhees
Munir Ghesani, MD
Mazyar Katouzian
Physician Founders
Clinical Leadership At The Center
Our physician founders bring expertise across radiology, nuclear medicine, clinical informatics, molecular imaging, and radiopharmaceutical therapy.
Eliot Siegel, MD
Radiology, nuclear medicine, medical informatics, digital imaging, artificial intelligence, and precision oncology.
Babak Saboury, MD
AI-enabled molecular imaging, quantitative imaging biomarkers, dosimetry, and radiopharmaceutical therapy.
Michael Morris, MD
Prostate cancer, neuroendocrine tumors, molecular imaging, radiopharmaceutical therapy, and dosimetry.
Next Step
Connect With United Theranostics
For patient, provider, or clinical trial questions, contact United Theranostics directly.